TABLE 3

Frequency of non-cancer-related mortality

	EB arm^# deaths	PGB arm^¶ deaths
Total non-cancer deaths	6 (5.6)	5 (4.5)
Pulmonary bleeding	1 (0.9)	0 (0)
Gastrointestinal perforation/peritonitis	2 (1.8)	1 (0.9)
Pulmonary embolism	2 (1.8)	0 (0)
Sepsis	0 (0)	2 (1.8)
Sudden cardiac death	1 (0.9)	2 (1.8)

Data are presented as n (%). EB: erlotinib/bevacizumab; PGB: cisplatin/gemcitabine/bevacizumab. ^#: n=108; ^¶: n=111.